Veru/$VERU
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Veru
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
Ticker
$VERU
Sector
Health
Primary listing
Employees
210
Headquarters
Website
Veru Metrics
BasicAdvanced
$46M
-
-$2.48
-0.71
-
Price and volume
Market cap
$46M
Beta
-0.71
52-week high
$3.83
52-week low
$2.64
Financial strength
Current ratio
3.804
Quick ratio
3.491
Long term debt to equity
12.548
Total debt to equity
16.101
Interest coverage (TTM)
-67.46%
Profitability
EBITDA (TTM)
-40.755
Gross margin (TTM)
34.67%
Net profit margin (TTM)
-215.24%
Operating margin (TTM)
-242.68%
Effective tax rate (TTM)
-2.39%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-49.03%
Return on equity (TTM)
-93.86%
Valuation
Price to revenue (TTM)
2.748
Price to book
2.21
Price to tangible book (TTM)
3.28
Price to free cash flow (TTM)
-1.589
Free cash flow yield (TTM)
-62.93%
Free cash flow per share (TTM)
-1.995
Growth
Revenue change (TTM)
134.43%
Earnings per share change (TTM)
-32.24%
3-year revenue growth (CAGR)
-34.64%
10-year revenue growth (CAGR)
-5.92%
3-year earnings per share growth (CAGR)
-10.61%
10-year earnings per share growth (CAGR)
8.73%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Veru stock?
Veru (VERU) has a market cap of $46M as of August 13, 2025.
What is the P/E ratio for Veru stock?
The price to earnings (P/E) ratio for Veru (VERU) stock is 0 as of August 13, 2025.
Does Veru stock pay dividends?
No, Veru (VERU) stock does not pay dividends to its shareholders as of August 13, 2025.
When is the next Veru dividend payment date?
Veru (VERU) stock does not pay dividends to its shareholders.
What is the beta indicator for Veru?
Veru (VERU) has a beta rating of -0.71. This means that it has an inverse relation to market volatility.